• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2100113 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-02-03 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd In Review 2021-02-03 view
JXHL1000159 GW685698/GW642444 fluticasone furoate;vilanterol Active ingredient Chemical Drugs Import Drug Application 2010-05-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd Certificate Issued 2011-01-27 view
JYHB2002759 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd In Review 2021-01-04 view
JYHB1701317 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs Supplementary Application 2017-11-03 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Certificate Issued 2018-09-07 view
JYHB1300731 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs Supplementary Application 2013-06-06 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Certificate Issued 2014-10-16 view
JYHB2001496 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2020-08-20 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd Filed 2020-08-31 view
JXHL0900438 GW685698/GW642444 fluticasone furoate;vilanterol Active ingredient Chemical Drugs Import Drug Application 2010-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd Certificate Issued 2010-12-30 view
JYHB1900923 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs Supplementary Application 2019-07-29 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Filed 2019-08-08 view
JXHL2000354 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Intellectual Property Development Ltd In Review 2021-01-04 view
JXHS1600079 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2017-01-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Certificate Issued 2018-08-07 view
JYHB1801219 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs Supplementary Application 2018-11-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Certificate Issued 2019-01-22 view
JXHL1100039 GW685698/GW642444 fluticasone furoate;vilanterol Active ingredient Chemical Drugs Import Drug Application 2011-02-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd Certificate Issued 2012-08-06 view
JYHB2001111 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs Supplementary Application 2020-06-28 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd Filed 2020-06-30 view
JXHL1500318 糠酸氟替卡松吸入粉雾剂 fluticasone furoate Powder for inhalation Chemical Drugs Import Drug Application 2016-01-15 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxosmithkline LLC Certificate Issued 2018-03-01 view
JYHB2100112 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-02-03 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd In Review 2021-02-03 view
JXHS1800025 糠酸氟替卡松乌美溴铵维兰特罗吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2018-06-28 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd Certificate Issued 2019-11-08 view
JXHL2000355 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Intellectual Property Development Ltd In Review 2021-01-04 view
JXHS1600080 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) fluticasone furoate;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2017-01-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Certificate Issued 2018-08-07 view
JYHB1801220 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs Supplementary Application 2018-10-09 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Filed 2018-10-15 view
JXHS1000085 糠酸氟替卡松鼻用喷雾剂 fluticasone furoate Spray Chemical Drugs Import Drug Application 2010-11-29 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd Certificate Issued 2012-06-12 view